355 related articles for article (PubMed ID: 16492153)
1. Use of an induced fit receptor structure in virtual screening.
Sherman W; Beard HS; Farid R
Chem Biol Drug Des; 2006 Jan; 67(1):83-4. PubMed ID: 16492153
[TBL] [Abstract][Full Text] [Related]
2. Protein flexibility in ligand docking and virtual screening to protein kinases.
Cavasotto CN; Abagyan RA
J Mol Biol; 2004 Mar; 337(1):209-25. PubMed ID: 15001363
[TBL] [Abstract][Full Text] [Related]
3. Novel procedure for modeling ligand/receptor induced fit effects.
Sherman W; Day T; Jacobson MP; Friesner RA; Farid R
J Med Chem; 2006 Jan; 49(2):534-53. PubMed ID: 16420040
[TBL] [Abstract][Full Text] [Related]
4. Optimization of high throughput virtual screening by combining shape-matching and docking methods.
Lee HS; Choi J; Kufareva I; Abagyan R; Filikov A; Yang Y; Yoon S
J Chem Inf Model; 2008 Mar; 48(3):489-97. PubMed ID: 18302357
[TBL] [Abstract][Full Text] [Related]
5. Fully automated molecular mechanics based induced fit protein-ligand docking method.
Koska J; Spassov VZ; Maynard AJ; Yan L; Austin N; Flook PK; Venkatachalam CM
J Chem Inf Model; 2008 Oct; 48(10):1965-73. PubMed ID: 18816046
[TBL] [Abstract][Full Text] [Related]
6. Analysis and optimization of structure-based virtual screening protocols (1): exploration of ligand conformational sampling techniques.
Good AC; Cheney DL
J Mol Graph Model; 2003 Sep; 22(1):23-30. PubMed ID: 12798388
[TBL] [Abstract][Full Text] [Related]
7. The use of protein-ligand interaction fingerprints in docking.
Brewerton SC
Curr Opin Drug Discov Devel; 2008 May; 11(3):356-64. PubMed ID: 18428089
[TBL] [Abstract][Full Text] [Related]
8. Receptor flexibility in de novo ligand design and docking.
Alberts IL; Todorov NP; Dean PM
J Med Chem; 2005 Oct; 48(21):6585-96. PubMed ID: 16220975
[TBL] [Abstract][Full Text] [Related]
9. Effective handling of induced-fit motion in flexible docking.
Mizutani MY; Takamatsu Y; Ichinose T; Nakamura K; Itai A
Proteins; 2006 Jun; 63(4):878-91. PubMed ID: 16532451
[TBL] [Abstract][Full Text] [Related]
10. Ensemble docking of multiple protein structures: considering protein structural variations in molecular docking.
Huang SY; Zou X
Proteins; 2007 Feb; 66(2):399-421. PubMed ID: 17096427
[TBL] [Abstract][Full Text] [Related]
11. Importance of molecular computer modeling in anticancer drug development.
Geromichalos GD
J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
[TBL] [Abstract][Full Text] [Related]
12. Virtual screening of biogenic amine-binding G-protein coupled receptors: comparative evaluation of protein- and ligand-based virtual screening protocols.
Evers A; Hessler G; Matter H; Klabunde T
J Med Chem; 2005 Aug; 48(17):5448-65. PubMed ID: 16107144
[TBL] [Abstract][Full Text] [Related]
13. ProPose: steered virtual screening by simultaneous protein-ligand docking and ligand-ligand alignment.
Seifert MH
J Chem Inf Model; 2005; 45(2):449-60. PubMed ID: 15807511
[TBL] [Abstract][Full Text] [Related]
14. Pharmacophore-based molecular docking to account for ligand flexibility.
Joseph-McCarthy D; Thomas BE; Belmarsh M; Moustakas D; Alvarez JC
Proteins; 2003 May; 51(2):172-88. PubMed ID: 12660987
[TBL] [Abstract][Full Text] [Related]
15. Multiple active site corrections for docking and virtual screening.
Vigers GP; Rizzi JP
J Med Chem; 2004 Jan; 47(1):80-9. PubMed ID: 14695822
[TBL] [Abstract][Full Text] [Related]
16. Managing protein flexibility in docking and its applications.
B-Rao C; Subramanian J; Sharma SD
Drug Discov Today; 2009 Apr; 14(7-8):394-400. PubMed ID: 19185058
[TBL] [Abstract][Full Text] [Related]
17. Receptor flexibility for large-scale in silico ligand screens: chances and challenges.
Fischer B; Merlitz H; Wenzel W
Methods Mol Biol; 2008; 443():353-64. PubMed ID: 18446296
[TBL] [Abstract][Full Text] [Related]
18. Towards in silico lead optimization: scores from ensembles of protein/ligand conformations reliably correlate with biological activity.
Popov VM; Yee WA; Anderson AC
Proteins; 2007 Feb; 66(2):375-87. PubMed ID: 17078091
[TBL] [Abstract][Full Text] [Related]
19. A method for induced-fit docking, scoring, and ranking of flexible ligands. Application to peptidic and pseudopeptidic beta-secretase (BACE 1) inhibitors.
Moitessier N; Therrien E; Hanessian S
J Med Chem; 2006 Oct; 49(20):5885-94. PubMed ID: 17004704
[TBL] [Abstract][Full Text] [Related]
20. Considerations in compound database preparation--"hidden" impact on virtual screening results.
Knox AJ; Meegan MJ; Carta G; Lloyd DG
J Chem Inf Model; 2005; 45(6):1908-19. PubMed ID: 16309298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
